...
机译:靶向生物治疗时代不可切除转移性结直肠癌患者的预后因素:k?HNE风险分类的相关性
Department of Hepato-Gastroenterology and Digestive Oncology University Hospital of Reims Reims;
Department of Hepato-Gastroenterology and Digestive Oncology University Hospital of Reims Reims;
Department of Hepato-Gastroenterology and Digestive Oncology University Hospital of Reims Reims;
Clinical Research Center University Hospital of Reims Reims France;
Department of Hepato-Gastroenterology Polyclinique Courlancy Reims France;
Department of Hepato-Gastroenterology Clinique Saint Vincent Epernay France;
Department of Hepato-Gastroenterology Centre Hospitalier Chalons-en-Champagne Chalons-en;
Department of Hepato-Gastroenterology Centre Hospitalier Auban-Mo?t Epernay France;
Department of Digestive Oncology Institut Jean Godinot Reims France;
Clinical Research Center University Hospital of Reims Reims France;
Department of Hepato-Gastroenterology and Digestive Oncology University Hospital of Reims Reims;
Colorectal neoplasm; Metastasis; Palliative chemotherapy; Prognosis;
机译:靶向生物治疗时代不可切除的转移性结直肠癌患者的预后因素:Khhne风险分类的相关性
机译:血管内皮生长因子靶向剂治疗转移结直肠癌患者整体存活的预后因素
机译:分子靶向药物时代转移性大肠癌患者生存的预后指标:改良的格拉斯哥预后评分
机译:使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA,BRAF,PIK3CA突变
机译:表皮生长因子靶向的染料木黄酮对乳腺癌的生物治疗。
机译:用AfliBercept和Folfiri(FluyouracilLeucovorinIrinotecan)作为转移结直肠癌患者的第二线治疗的预后因素
机译:利用多元分析术后复制术后并发症和预后因子的危险因素